Influence of lysosomal sequestration on multidrug resistance in cancer cells

Abstract

Chemotherapy remains a primary treatment modality for various malignancies. However, resistance to chemotherapeutic drugs is a major obstacle to curative cancer therapy. Lysosomes are acidic organelles that participate in cellular digestion. However, there is rising interest in lysosomes because of their involvement with cancer. For example, extracellular secretion of lysosomal enzymes promote tumorigenesis; cytosolic leakage of lysosomal hydrolases promote apoptosis; and weak chemotherapeutic bases diffuse across the lysosomal membrane and become entrapped in lysosomes in their cationic state. Lysosomal drug sequestration lowers the cytotoxic potential of chemotherapeutics, reduces drug availability to sites of action, and contributes to cancer resistance. This review examines various mechanisms of lysosomal drug sequestration and their consequences on cancer multidrug resistance. Strategies for overcoming drug resistance by exploiting lysosomes as subcellular targets to reverse drug sequestration and drug resistance are also discussed.

Keywords

Lysosomal sequestration / lysosomes / chemotherapeutics / multidrug resistance / cancer / permeability-glycoprotein / exocytosis

References

[1] de Duve C.The lysosome turns fifty..Nat Cell Biol2005;7:847-9

[2] Guan JJ,Sun W,Wu JC.DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX..Cell Death Dis2015;6:e1624 PMCID:PMC4669745

[3] Salvador N,Horst M.Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state..J Biol Chem2000;275:27447-56

[4] Guillaumot P,Malek M,Brugière S.Pdro, a protein associated with late endosomes and lysosomes and implicated in cellular cholesterol homeostasis..PLoS One2010;5:e10977 PMCID:PMC2882324

[5] Kon S,Satake M.Altered trafficking of mutated growth factor receptors and their associated molecules: implication for human cancers..Cell Logist2014;4:e28461 PMCID:PMC4156482

[6] Goh LK.Endocytosis of receptor tyrosine kinases..Cold Spring Harb Perspect Biol2013;5:a017459 PMCID:PMC3632065

[7] Mohamed MM.Cysteine cathepsins: multifunctional enzymes in cancer..Nat Rev Cancer2006;6:764-75

[8] Vlodavsky I,Ilan N.Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications..Rambam Maimonides Med J2011;2:e0019 PMCID:PMC3678787

[9] Palermo C.Cysteine cathepsin proteases as pharmacological targets in cancer..Trends Pharmacol Sci2008;29:22-8

[10] Wang B,Kitamoto S,Grubb A.Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors..J Biol Chem2006;281:6020-9

[11] Podgorski I,Sameni M,Bhagat S.Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer..Neoplasia2005;7:207-23 PMCID:PMC1501133

[12] Boya P,Poncet D,Perfettini JL.Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion..J Exp Med2003;197:1323-34 PMCID:PMC2193790

[13] Kirkegaard T.Lysosomal involvement in cell death and cancer..Biochim Biophys Acta2009;1793:746-54

[14] Fehrenbacher N.Lysosomes as targets for cancer therapy..Cancer Res2005;65:2993-5

[15] Groth-Pedersen L.Combating apoptosis and multidrug resistant cancers by targeting lysosomes..Cancer Lett2013;332:265-74

[16] Holohan C,Longley DB.Cancer drug resistance: an evolving paradigm..Nat Rev Cancer2013;13:714-26

[17] Higgins CF.Multiple molecular mechanisms for multidrug resistance transporters..Nature2007;446:749-57

[18] Al-Akra L,Sahni S,Park KC.Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones..J Biol Chem2018;293:3562-87 PMCID:PMC5846167

[19] Rajagopal A.Subcellular localization and activity of multidrug resistance proteins..Mol Biol Cell2003;14:3389-99 PMCID:PMC181575

[20] Kunjachan S,Storm G,Lammers T.Multidrug resistance: Physiological principles and nanomedical solutions..Adv Drug Deliv Rev2013;65:1852-65 PMCID:PMC3939439

[21] Shapira A,Broxterman HJ.Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance..Drug Resist Updat2011;14:150-63

[22] Goldman SDB,Rajewski RA.Mechanisms of amine accumulation in, and egress from, lysosomes..Bioanalysis2009;1:1445-59 PMCID:PMC3065188

[23] Kazmi F,Pope C,Loewen GJ.Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)..Drug Metab Dispos2013;41:897-905 PMCID:PMC3608459

[24] Gotink KJ,Labots M,Dekker H.Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance..Clin Cancer Res2011;17:7337-46 PMCID:PMC4461037

[25] Hurwitz SJ,Mizunuma N.Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes..Blood1997;89:3745-54

[26] Adar Y,Bram EE,van den Bergh H.Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers..Cell Death Dis2012;3:e293 PMCID:PMC3358008

[27] Herlevsen M,Owens CR,Theodorescu D.Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes..Mol Cancer Ther2007;6:1804-13

[28] Ndolo RA,Duan S,Krise JP.Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro..PLoS One2012;7:e49366 PMCID:PMC3492287

[29] Marshall LA,Hofmann L,Schneider E.Increased lysosomal uptake of methotrexate-polyglutamates in two methotrexate-resistant cell lines with distinct mechanisms of resistance..Biochem Pharmacol2005;71:203-13

[30] Jansen G,Kathmann I,Priest DG.Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation,expanded folate pools, and intralysosomal drug sequestration..Mol Pharmacol1999;55:761-9

[31] Li W,Nordgren G,Dubowchik GM.Induction of cell death by the lysosomotropic detergent MSDH..FEBS Lett2000;470:35-9

[32] Cirman T,Mazovec GD,Reed JC.Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins..J Biol Chem2004;279:3578-87

[33] Kågedal K,Svensson I.Sphingosine-induced apoptosis is dependent on lysosomal proteases..Biochem J2001;359:335-43 PMCID:PMC1222151

[34] Erdal H,Castro J,Shoshan MC.Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis..Proc Natl Acad Sci USA2005;102:192-7 PMCID:PMC544072

[35] Ostenfeld MS,Bastholm L,Olsen OD.Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation..Autophagy2008;4:487-99

[36] Groth-Pedersen L,Høyer-Hansen M,Jäättelä M.Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine..Cancer Res2007;67:2217-25

[37] Rammer P,Kirkegaard T,Rytter A.BAMLET activates a lysosomal cell death program in cancer cells..Mol Cancer Ther2010;9:24-32

[38] Hahne JC,Meyer SR,Engel JB.Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer..Arch Gynecol Obstet2015;291:131-41

[39] Yi YW,Kim HJ,Wang A.Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells..Mol Carcinog2013;52:667-75 PMCID:PMC3586771

[40] Martin-Fernandez C,Hodgkinson C,Welham MJ.Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs..Mol Cancer Res2009;7:955-65 PMCID:PMC2882620

[41] Mousavi SA,Berg T.Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes..Biochem J2003;372:861-9 PMCID:PMC1223449

[42] Silverman GA,Cataltepe S,Kamachi Y.SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21.3..Tumour Biol1998;19:480-7

[43] Suminami Y,Kato H.Biological role of SCC antigen..Tumour Biol1998;19:488-93

[44] Kirkegaard T,Petersen NH,Olsen OD.Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology..Nature2010;463:549-53

[45] Nylandsted J,Danielewicz A,Lademann U.Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization..J Exp Med2004;200:425-35 PMCID:PMC2211935

[46] Gyrd-Hansen M,Jäättelä M.Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity..Cell Cycle2004;3:1484-5

[47] Altan N,Schindler M.Defective acidification in human breast tumor cells and implications for chemotherapy..J Exp Med1998;187:1583-98 PMCID:PMC2212293

[48] Englinger B,Senkiv J,Gabler L.Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer..J Exp Clin Cancer Res2017;36:122 PMCID:PMC5590147

[49] Zhitomirsky B.Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance..Oncotarget2015;6:1143-56 PMCID:PMC4359223

[50] Mayer LD,Cullis PR.Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient..Biochim Biophys Acta1986;857:123-6

[51] Angus DW,Mason R.The potential influence of CO2, as an agent for euthanasia, on the pharmacokinetics of basic compounds in rodents..Drug Metab Dispos2008;36:375-9

[52] Colombo F,Cetrangolo P,Razini P.Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells..PLoS One2014;9:e114787 PMCID:PMC4262459

[53] Reck M,von Pawel J,Bondarenko I.Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel..Lung Cancer2015;90:267-73

[54] Mross K,Frost A,Stopfer P.Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis..BMC Cancer2014;14:510 PMCID:PMC4105047

[55] Molife LR,Jones RJ,Bloomfield D.Randomized phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer..Future Oncol2014;10:219-31

[56] Kutluk Cenik B,Gerber DE.BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer..Mol Cancer Ther2013;12:992-1001 PMCID:PMC3681897

[57] Burger H,Segeletz S,de Bruijn P.Lysosomal sequestration determines intracellular imatinib levels..Mol Pharmacol2015;88:477-87

[58] Kalayda GV,Buss I,Jaehde U.Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells..BMC Cancer2008;8:175 PMCID:PMC2442842

[59] Safaei R,Cheng TC,Otani S.Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells..Mol Cancer Ther2005;4:1595-604

[60] Settembre C,Medina DL,Erdin S.A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB..EMBO J2012;31:1095-108 PMCID:PMC3298007

[61] Martina JA,Gucek M.MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB..Autophagy2012;8:903-14 PMCID:PMC3427256

[62] Medina DL,Peluso I,De Stefani D.Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB..Nat Cell Biol2015;17:288-99 PMCID:PMC4801004

[63] Sardiello M,di Ronza A,Valenza M.A gene network regulating lysosomal biogenesis and function..Science2009;325:473-7

[64] Gotink KJ,de Haas RR,Dekker H.Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib..Cell Oncol (Dordr)2015;38:119-29 PMCID:PMC4555235

[65] Martina JA.Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes..J Cell Biol2013;200:475-91 PMCID:PMC3575543

[66] Syed SB,Fu IH,Periyasamy L.Targeting P-glycoprotein: investigation of piperine analogs for overcoming drug resistance in cancer..Sci Rep2017;7:7972 PMCID:PMC5554262

[67] Sinha BK,Mason RP.Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells..Biochim Biophys Acta Gen Subj2018;1862:2806-14 PMCID:PMC6195836

[68] Yamagishi T,Sharp DM,Jansson PJ.P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration..J Biol Chem2013;288:31761-71 PMCID:PMC3814770

[69] Forgac M.Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology..Nat Rev Mol Cell Biol2007;8:917-29

[70] Shiraishi N,Kobayashi M.Lysosomotropic agents reverse multiple drug resistance in human cancer cells..Cancer Lett1986;30:251-9

[71] Katayama K,Ohnuma S,Swaim W.Revealing the fate of cell surface human P-glycoprotein (ABCB1): the lysosomal degradation pathway..Biochim Biophys Acta2015;1853:2361-70 PMCID:PMC4558211

[72] Palmeira A,Vasconcelos MH.Three decades of P-gp inhibitors: skimming through several generations and scaffolds..Curr Med Chem2012;19:1946-2025

[73] Chapuy B,Radunski U,Wenzel D.ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug..Haematologica2009;94:1528-36 PMCID:PMC2770963

[74] Rodríguez A,Ortego J.Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells..J Cell Biol1997;137:93-104 PMCID:PMC2139854

[75] Medina DL,Bouche V,Mansueto G.Transcriptional activation of lysosomal exocytosis promotes cellular clearance..Dev Cell2011;21:421-30 PMCID:PMC3173716

[76] Sundler R.Lysosomal and cytosolic pH as regulators of exocytosis in mouse macrophages..Acta Physiol Scand1997;161:553-6

[77] Kallunki T,Jäättelä M.Cancer-associated lysosomal changes: friends or foes?.Oncogene2013;32:1995-2004

[78] Ouar Z,Vignes C,Pringel C.Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells..Biochem J2003;370:185-93 PMCID:PMC1223162

[79] Gotink KJ,Honeywell RJ,de Haas RR.Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature..Oncoscience2014;1:844-53 PMCID:PMC4303892

[80] Li Y,Jing L,Yan Y.Lysosome inhibitors enhance the chemotherapeutic activity of doxorubicin in hepg2 cells..Chemotherapy2017;62:85-93

[81] Wang E,Dunn KW.Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells..J Cell Physiol2000;184:263-74

[82] Circu M,Barr MP,Mills G.Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells..PLoS One2017;12:e0184922 PMCID:PMC5612465

[83] Wang Y,Li DD,Wu XQ.Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells..Chin J Cancer2011;30:690-700 PMCID:PMC4012269

[84] Lovejoy DB,Brunk UT,Ponka P.Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes..Cancer Res2011;71:5871-80

[85] Yang X,Pilla S,Gong S.Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy..Bioconjug Chem2010;21:496-504

[86] Ríhová B,Pechar M,Stastný M.Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes..J Control Release2001;74:225-32

[87] Lai PS,Peng CL,Yen WN.Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy..J Control Release2007;122:39-46

[88] Minko T,Pozharov V.HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line..J Control Release1998;54:223-33

[89] Nowak-Sliwinska P,van Beijnum JR,Kilarski WW.Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition..Cell Death Dis2015;6:e1641 PMCID:PMC4669819

[90] Seebacher NA,Jansson PJ.Glucose modulation induces lysosome formation and increases lysosomotropic drug sequestration via the P-glycoprotein drug transporter..J Biol Chem2016;291:3796-820 PMCID:PMC4759162

[91] Seebacher NA,Jansson PJ.A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC..Cell Death Dis2016;7:e2510 PMCID:PMC5261000

[92] Jansson PJ,Arvind A,Gutierrez E.Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)..J Biol Chem2015;290:9588-603 PMCID:PMC4392262

[93] Weinberg ED.Iron withholding: a defense against infection and neoplasia..Physiol Rev1984;64:65-102

[94] Xie H.Role of copper in angiogenesis and its medicinal implications..Curr Med Chem2009;16:1304-14

[95] Hassouneh B,Nagel T,Merajver SD.Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer..Mol Cancer Ther2007;6:1039-45

[96] Cuvier C,Millot JM,Chevillard S.Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance..Biochem Pharmacol1992;44:509-17

[97] Elbayoumi TA.Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines..Eur J Pharm Sci2007;32:159-68 PMCID:PMC2151083

[98] Ono K,Han J.Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death..Mol Cell Biol2003;23:665-76 PMCID:PMC151543

[99] Eaton JW.Molecular bases of cellular iron toxicity..Free Radic Biol Med2002;32:833-40

[100] Xue Z,Li J,Han J.Bifunctional super-resolution imaging probe with acidity-independent lysosome-retention mechanism..Anal Chem2018;90:11393-400

[101] Zhitomirsky B.Lysosomes as mediators of drug resistance in cancer..Drug Resist Updat2016;24:23-33

[102] Kornhuber J,Groemer TW,Welzel O.Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system..J Cell Physiol2010;224:152-64

[103] Fu D,Zhu WS,Wang YK.Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering..Nat Chem2014;6:614-22 PMCID:PMC4205760

[104] Fehrenbacher N,Poulsen B,Kallunki T.Sensitization to the lysosomal cell death pathway upon immortalization and transformation..Cancer Res2004;64:5301-10